Actinium Pharmaceuticals, Inc.
ATNM
$1.34
-$0.05-3.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M |
| Total Depreciation and Amortization | 204.00K | 202.00K | 189.00K | 216.00K | 199.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.20M | 1.34M | 1.37M | 1.38M | 927.00K |
| Change in Net Operating Assets | -506.00K | -1.95M | 1.82M | -298.00K | 708.00K |
| Cash from Operations | -5.75M | -11.98M | -7.97M | -7.37M | -7.49M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -11.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -11.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00K | -2.00K | -3.00K | -2.00K | -1.00K |
| Issuance of Common Stock | -- | 4.60M | 9.96M | 14.77M | 1.19M |
| Repurchase of Common Stock | -1.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.00K | 4.60M | 9.95M | 14.77M | 1.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.75M | -7.37M | 1.98M | 7.38M | -6.30M |
